We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTS icon
2051
Virtus Investment Partners
VRTS
$1.1B
$2.57K ﹤0.01%
13
NCNO icon
2052
nCino
NCNO
$2.1B
$2.56K ﹤0.01%
85
+51
+150% +$1.3K
BLMN icon
2053
Bloomin' Brands
BLMN
$938M
$2.56K ﹤0.01%
95
+11
+13% +$275
XNCR icon
2054
Xencor
XNCR
$1.55B
$2.55K ﹤0.01%
102
+75
+278% +$2.04K
CRI icon
2055
Carter's
CRI
$1.47B
$2.54K ﹤0.01%
35
+18
+106% +$1.22K
KEX icon
2056
Kirby Corp
KEX
$6.93B
$2.54K ﹤0.01%
33
-3
-8% -$216
AUPH icon
2057
Aurinia Pharmaceuticals
AUPH
$2.11B
$2.54K ﹤0.01%
262
MARA icon
2058
Marathon Digital Holdings
MARA
$3.9B
$2.54K ﹤0.01%
183
-119
-39% -$1.2K
JJSF icon
2059
J&J Snack Foods
JJSF
$1.71B
$2.53K ﹤0.01%
16
MWA icon
2060
Mueller Water Products
MWA
$4.16B
$2.53K ﹤0.01%
156
LAND
2061
Gladstone Land Corp
LAND
$360M
$2.52K ﹤0.01%
155
+91
+142% +$1.47K
PDSB icon
2062
PDS Biotechnology
PDSB
$43.4M
$2.52K ﹤0.01%
500
FSR
2063
DELISTED
Fisker Inc.
FSR
$2.52K ﹤0.01%
446
+368
+472% +$2.12K
TCMD icon
2064
Tactile Systems Technology
TCMD
$665M
$2.49K ﹤0.01%
100
+14
+16% +$291
ESE icon
2065
ESCO Technologies
ESE
$7.92B
$2.49K ﹤0.01%
24
LCTX icon
2066
Lineage Cell Therapeutics
LCTX
$278M
$2.47K ﹤0.01%
1,754
IHRT icon
2067
iHeartMedia
IHRT
$583M
$2.47K ﹤0.01%
678
+367
+118% +$1.22K
COGT icon
2068
Cogent Biosciences
COGT
$7.24B
$2.46K ﹤0.01%
208
GOLF icon
2069
Acushnet Holdings
GOLF
$5.45B
$2.46K ﹤0.01%
45
+6
+15% +$297
SAVE
2070
DELISTED
Spirit Airlines, Inc.
SAVE
$2.45K ﹤0.01%
143
-274
-66% -$4.49K
ASIX icon
2071
AdvanSix
ASIX
$444M
$2.45K ﹤0.01%
70
+13
+23% +$471
NARI
2072
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.44K ﹤0.01%
42
-21
-33% -$1.32K
ORGO icon
2073
Organogenesis Holdings
ORGO
$239M
$2.44K ﹤0.01%
735
+474
+182% +$1.4K
CMPR icon
2074
Cimpress
CMPR
$2.31B
$2.44K ﹤0.01%
41
BUSE icon
2075
First Busey Corp
BUSE
$2.56B
$2.43K ﹤0.01%
121
-236
-66% -$4.53K

Similar funds

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.